[Transition from pediatric to adult care: experience of a cystic fibrosis care center].
OBJECTIVE
Even though patients with cystic fibrosis (CF) are continuously improving their life expectancy, guidelines for transition to adult services have not been clearly determined yet. The aim of this study was to analyze the management of this transition in the CF care center of Angers, France.


METHODS
From their medical files, we analyzed the transfer of 22 patients with CF from pediatric to adult care. The perceptions of patients and caregivers regarding this transition were evaluated using anonymous questionnaires.


RESULTS
The initial objective was to transfer patients around 18 years of age, offering them 3 or 4 joint consultations with a pediatrician and adult lung specialist. The median age of transfer was 22 years and the median duration of the transition period was 9 months. Half of the patients had only 1 joint transfer consultation during transition. The patient reaching the age of 18 and maturity were the most common criteria mentioned for transfer. All highlighted problems leaving the pediatric team they had grown attached to and its familiar environment. Caregivers described the transfer as a success, whereas half of the patients were dissatisfied with it, with both patients and caregivers indicating that the transition was too short without enough joint consultations.


CONCLUSIONS
This study shows that this period is a major life event for the patient with CF. The transition process must be organized with the patient and independent behaviors should be encouraged. Adult and pediatric teams need to cooperate. Based on this experience and former medical data, we suggest a transition program for patients with CF.
Malbrunot-Wagner
A-C
AC
Département de pédiatrie, CHU d'Angers, 4, rue Larrey, 49933 Angers cedex 9, France.
Bonnemains
C
C
Troussier
F
F
Darviot
E
E
Chiffoleau
M
M
Person
C
C
Urban
T
T
Giniès
J-L
JL
D000293:Adolescent; D016497:Adolescent Health Services; D003266:Continuity of Patient Care; D003550:Cystic Fibrosis / Q000628:therapy*; D005260:Female; D005602:France; D006801:Humans; D008297:Male; D011787:Quality of Health Care; D055815:Young Adult